Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C1323099 (sympathomimetic)
 2,957 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In mild hypertension, a betablocker treatment could reduce cardiovascular events. But in smoking men the benefit disappears and this interaction is unexplained. In 6 healthy non smoking men, we studied the effects of acute oral administration of propranolol (80 mg) pindolol (15 mg) and placebo after cigarette smoking (CS) (two cigarettes within 10 minutes). In a double blind cross over randomized study, arterial pressure and heart rate (HR) were recorded within 20 minutes after CS. Brachial artery diameter (D), Local vascular Resistance (RL), Local arterial Compliance (CL) and pulse wave velocity (VOP) were determined non invasively (using a pulsed doppler system) before and 20 mn after CS. Under placebo, mean arterial pressure (PAM), HR and RL increased significantly after CS (+9.2 +/- 3 mmHg, +4.5 +/- 3 b/mn and +36 +/- 14 per cent, respectively). These modifications were not different after propranolol, pindolol or placebo (ANOVA). Arterial distensibility (CL) was decreased after CS and this alteration was not prevented by beta-blockers. Brachial artery diameter was not modified after CS. Our results demonstrate that acute treatment with non selective beta-blockers with or without sympathomimetic intrinsic activity does not prevent haemodynamic modifications induced by cigarette smoking.
 ...
PMID:[Effects of beta-blockers on hemodynamics of the forearm after tobacco stimulation]. 290 27

During the 1972 Olympic Games, a 16 year old American athlete was compelled to return a gold medal and was disqualified from further participation. Rick Demont had used a sympathomimetic drug (ephedrine) prior to competition for treatment of his asthma as prescribed by his physician. The present research was carried out to investigate whether the administration of a sympathomimetic drug enhances maximal performance in the normal healthy individual in terms of physiological and psychological processes? Ten subjects participated in a double-blind, cross-over, counterbalanced incremental cycle ergometer test on two different occasions, once after ingesting placebo, once after ingesting ephedrine. Repeated measures ANOVA's revealed no significant differences in any of the cardiopulmonary (VE, VO2, VCO2, RQ and AT), cardiovascular (HR, BP, O2 Pulse, RPP) and psychophysiological (RPE) variables between treatments. Findings in the current investigation suggest that no advantage is obtained with the use of sympathomimetic drugs to augment one's maximal aerobic capacity.
 ...
PMID:Sympathomimetics and exercise enhancement: all in the mind? 368 71